Ruby ROSE evaluation
Diagnostic TestCreation and digitization of ROSE slides produced using Ruby's instrument from bronchoscopic biopsy samples
NCT Number: NCT06499454
The goal of this study is to learn whether the Ruby Robotics system enables pathologists to determine whether a bronchoscopic biopsy sample is adequate for diagnosis. The main question it aims to answer is:
- Are pathologists' evaluations of Ruby digital images concordant with their evaluations of manually created rapid on-site evaluation slides?
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Creation and digitization of ROSE slides produced using Ruby's instrument from bronchoscopic biopsy samples
Time frame: 2 months from time of sample collection
Time frame: 2 months from time of sample collection
Ruby Robotics Inc
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06563050
Lidocaine Spray, Lung Cancer
View Trial DetailsNCT06004440
Lung Cancer, Lung Diseases
Orlando, Florida, United States
View Trial DetailsNCT05854563
Infections, Lung Cancer
The Bronx, New York, United States
View Trial DetailsNCT04614129
Lung Cancer, Lung Diseases
Boston, Massachusetts, United States
View Trial Details